arrow
B

Bernadette Liemberger

eb research institute gmbh
H指数:7
被引数:179

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RiboScreenTM Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease

RiboScreenTM技术将小分子核糖体药物递送至细胞,将核糖体蛋白转化为分子阀门,以调节罕见病和常见病中定制化的蛋白质生产水平

2026-06-240
OA
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa

连接性表皮松解症的潜在治疗策略:碱基编辑

2025-10-300
OAAI
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
2022-08-0115
OAAI